J&J Kept Quiet on Popular Diabetes Drug as Red Flags Multiplied

Gathered for an emergency meeting, the Johnson & Johnson drug safety team painted an alarming scene: people taking the company's new blockbuster diabetes drug were falling gravely ill.

Related Keywords

United States ,Canada ,South Korea ,Mississippi ,Japan ,Chattanooga ,Tennessee ,Alabama ,Portland ,Oregon ,United Kingdom ,Raritan ,New Jersey ,China ,San Diego ,California ,Toronto ,Ontario ,Titusville ,University Of Southern California ,Americans ,Chinese ,Han ,Japanese ,Alex Gorsky ,Neelima Chu ,Susan Bersoff ,Eli Lilly ,Michael Clark ,Jacqueline Coelln Hough ,Ali Niak ,Mehul Desai ,Nanne Peters ,Michael Fralick ,Veronica Ryan ,Shujian Wu ,Christine Chamberlain ,Gary Meininger ,Angelina Trujillo ,Bruce Leslie ,David Polidori ,Security Administration ,Boehringer Ingelheim ,Drug Administration ,Astrazeneca Plc ,Clinical Diabetes Program ,Reuters ,University Of Toronto ,Mitsubishi ,European Medicines Agency ,Bristol Myers Squibb ,Mitsubishi Tanabe Pharma Corp ,Johnson ,Chief Executive Officer Alex Gorsky ,Social Security Administration ,Janssen Pharmaceutical ,Sharp Healthcare ,Bristol Myers ,Seong Won Han ,European Medicines ,Southern California ,Mitsubishi Tanabe ,Susan Bersoff Matcha ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Diabetes Mellitus ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Diabetic Ketoacidosis ,Diabetes Mellitus Type 1 ,Iabetes Mellitus Type I ,Type 1 Diabetes ,Endocrinology ,Ndocrine System ,Sglt2 Inhibitors ,Odium Glucose Transporter 2 Inhibitors ,Odium Glucose Co Transporter 2 Inhibitors ,Podiu ,